Back to Search
Start Over
Decoys Selection in Benchmarking Datasets: Overview and Perspectives
- Source :
- Frontiers in Pharmacology, Frontiers in Pharmacology, Vol 9 (2018)
- Publication Year :
- 2017
-
Abstract
- Virtual Screening (VS) is designed to prospectively help identifying potential hits, i.e., compounds capable of interacting with a given target and potentially modulate its activity, out of large compound collections. Among the variety of methodologies, it is crucial to select the protocol that is the most adapted to the query/target system under study and that yields the most reliable output. To this aim, the performance of VS methods is commonly evaluated and compared by computing their ability to retrieve active compounds in benchmarking datasets. The benchmarking datasets contain a subset of known active compounds together with a subset of decoys, i.e., assumed non-active molecules. The composition of both the active and the decoy compounds subsets is critical to limit the biases in the evaluation of the VS methods. In this review, we focus on the selection of decoy compounds that has considerably changed over the years, from randomly selected compounds to highly customized or experimentally validated negative compounds. We first outline the evolution of decoys selection in benchmarking databases as well as current benchmarking databases that tend to minimize the introduction of biases, and secondly, we propose recommendations for the selection and the design of benchmarking datasets.
- Subjects :
- 0301 basic medicine
Computer science
Review
Machine learning
computer.software_genre
03 medical and health sciences
benchmarking databases
Pharmacology (medical)
benchmarking
decoy
Selection (genetic algorithm)
Protocol (science)
Pharmacology
Virtual screening
business.industry
lcsh:RM1-950
Benchmarking
virtual screening
lcsh:Therapeutics. Pharmacology
030104 developmental biology
structure-based drug design
Artificial intelligence
ligand-based drug design
business
Decoy
computer
Subjects
Details
- ISSN :
- 16639812
- Volume :
- 9
- Database :
- OpenAIRE
- Journal :
- Frontiers in pharmacology
- Accession number :
- edsair.doi.dedup.....affd519fdc007bca5aed5aa7781bfe2b